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A B S T R A C T
The embryonic aorta produces hematopoietic stem and progenitor cells from a hemogenic endothelium
localized in the aortic floor through an endothelial to hematopoietic transition. It has been long proposed that
the Bone Morphogenetic Protein (BMP)/Transforming Growth Factor ß (TGFß) signaling pathway was
implicated in aortic hematopoiesis but the very nature of the signal was unknown. Here, using thorough
expression analysis of the BMP/TGFß signaling pathway members in the endothelial and hematopoietic
compartments of the aorta at pre-hematopoietic and hematopoietic stages, we show that the TGFß pathway is
preferentially balanced with a prominent role of Alk1/TgfßR2/Smad1 and 5 on both chicken and mouse species.
Functional analysis using embryonic stem cells mutated for Acvrl1 revealed an enhanced propensity to produce
hematopoietic cells. Collectively, we reveal that TGFß through the Alk1/TgfßR2 receptor axis is acting on
endothelial cells to produce hematopoiesis.
1. Introduction
Hematopoietic Stem and Progenitor Cells (HSPCs) are normally
localized in the bone marrow where they are responsible for the life-
long maintenance of the adult hematopoietic system. HSPCs are
however produced early during development in the Aorta-Gonads-
Mesonephros (AGM) region (Medvinsky and Dzierzak, 1996; Müller
et al., 1994) from a specialized subset of endothelial cells (ECs)
designated as hemogenic. HSPC production in the aorta is polarized
to the aortic floor and appears as cell clusters thereafter referred as to
Intra-Aortic Hematopoietic Clusters (IAHCs). In most vertebrate
species, IAHCs lay in the aortic floor in close association with the
endothelium. The only exception is the mouse wherein IAHCs are
found both ventrally and dorsally although hematopoietic stem cells
are restricted to the ventral part of the vessel (Taoudi and Medvinsky,
2007; Yokomizo and Dzierzak, 2010).
Cell-tracing experiments in chicken (Jaffredo et al., 2000, 1998)
and mouse (Chen et al., 2009; de Bruijn et al., 2002; Sugiyama et al.,
2003; Zovein et al., 2008) species indicate that IAHCs derive from
hemogenic ECs through an Endothelial-to-Hematopoietic Transition
(EHT). Time-lapse imaging techniques have documented this transi-
tion in mouse Embryonic Stem (ES) cells (Eilken et al., 2009; Lancrin
et al., 2009) and have allowed to directly monitor HSPC formation in
zebrafish (Bertrand et al., 2010; Kissa and Herbomel, 2010; Lam et al.,
2010) and mouse embryos (Boisset et al., 2010) suggesting highly
conserved mechanisms between species.
One of the key players for the hemogenic endothelium and IAHCs is
the transcription factor Runx1. Runx1 is expressed in IAHCs of mouse
(North et al., 2002), Xenopus (Ciau-Uitz et al., 2000) zebrafish (Lam et al.,
2010) and chicken (Richard et al., 2013) embryo and is required for their
proper emergence (Chen et al., 2009; North et al., 1999) during EHT
(Chen et al., 2009). Moreover, the use of ES cell cultures has also disclosed
the critical role of Runx1 for hematopoietic cell (HC) budding from the
hemogenic endothelium (Lancrin et al., 2009). Recently, we reported that
the sub-aortic mesenchyme is required in vivo to initiate RUNX1
expression in hemogenic ECs and to allow emergence of IAHCs (Richard
et al., 2013). Despite these advances, the molecular signal(s) triggering
hematopoietic commitment and IAHC formation is yet to be defined.
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One potential signaling pathway controlling aortic hematopoiesis
from hemogenic ECs is the BMP/TGFß axis. BMP4 has been found
expressed in the subaortic mesenchyme in mouse (Durand et al., 2007),
human (Marshall et al., 2000) and zebrafish (Wilkinson et al., 2009) and
inhibition of BMP signaling was shown to decrease the number of aorta-
associated HSPCs (Durand et al., 2007). A link between tgfß/bmp and
runx1 has also been reported in Xenopus, (Walmsley et al., 2002). Both
Runx1 and the BMP/TGFß inhibitory protein Smad 6 (SMAD6) were
shown to be transcriptionally regulated by BMP (Knezevic et al., 2011;
Pimanda et al., 2007). TGFß1 is expressed by IAHCS during human
development suggesting a role in embryonic hematopoiesis (Marshall
et al., 2000). Recently, active TGFß signaling was shown to promote EC
differentiation at the expense of HC in an ES cell differentiation model
(Vargel et al., 2016) and to trigger hemogenic EC commitment and EHT
in the developing zebrafish (Monteiro et al., 2016). Genetic studies in
mouse and human have also provided strong evidence for a prominent
role of TGFß signaling in normal and pathological EC function during
vascular formation (Pardali et al., 2010). In particular TGFß was
proposed to regulate the activation state of ECs between proliferation
and quiescence (Goumans et al., 2002; Oh et al., 2000). In this context,
VE-Cadherin has been reported to be a strong regulator of TGFß
signaling linking the endothelial phenotype to the proper functioning of
TGFß-associated receptors (Rudini et al., 2008). Of note, TGFß has also
been assigned as one of the key players in Epithelial to Mesenchymal
Transition (EMT), a mechanism involved in development, tissue repair
and cancer (Kalluri and Weinberg, 2009; Lamouille et al., 2014), that
closely resembles EHT (Goossens et al., 2011).
The TGFβ signaling pathway includes Bone morphogenetic proteins
(BMPs), Growth and differentiation factors (GDFs), Anti-Müllerian
Hormone (AMH), Activin, Nodal and TGFβ’s, seven type I Activin-like
kinase receptors (ALK1 to 7 also designated as ACVRL1, ACVR1,
BMPR1A, ACVR1B, TGFßR1, BMPR1B and ACVR1C respectively), four
type II serine-threonine kinase receptors (TGFβRII, BMPRII, ACTRIIA,
ACTRIIB) and two type III receptors (Endoglin (Eng) and Betaglycan)
(Supplementary Table 1) see also (Miyazono et al., 2010). Upon binding
of one of the ligands to type II receptors, a specific type I receptor is
recruited and activated by phosphorylation of a conserved amino acid
sequence, the GS-domain. Phosphorylation of signaling molecules named
Smads takes place in the cytoplasm. Phosphorylated Smads (P-Smads)
associate with a co-Smad (Smad4) and migrate to the nucleus to regulate
target genes. Classically, BMP receptor regulated-Smads (Smads1/5/8)
are phosphorylated by the ACVRL1/ACVR1 group (ALK1/2) and
BMPR1-group (ALK3/6) receptors, whereas TGFβ receptor-regulated-
Smads (Smads2/3) are phosphorylated by the TGFβR1-group (ALK4/5/
7) (Miyazono et al., 2010; Shi and Massague, 2003). However this Smad
code is broken in ECs wherein TGFß-mediated proliferation and
differentiation occur through a precise balance between ACVRL1 and
TGFßRI signaling followed by the recruitment of R-SMADS 1–5 or R-
SMADS 2–3 respectively (Goumans et al., 2002; Lebrin et al., 2004).
In the present study, we have investigated the BMP/TGFß signaling
pathway in the context of aortic hematopoiesis using chicken and
mouse species by studying the expression of 6 type I, 3 type II and 2
type III receptors, 7 ligands, and 8 Smads. Our data identified the
TGFß pathway, in particular the type I and type II receptors, Acvrl1
(Alk1) and TgfßR2 respectively, as a hallmark of AGM ECs.
Hematopoietic commitment decreased the expression of these two
receptors and their associated Smad signaling in IAHCs. Importantly,
ES cells heterozygous for Acvrl1 (Acvrl1+/-) displayed an enhanced
propensity to generate HC. Collectively, our results will help better
manipulating cells to produce hematopoiesis from ECs.
2. Material and methods
2.1. FACS sorting
Chicken eggs (Gallus gallus JA57 strain) were incubated at 38 ±
1 °C in a humidified atmosphere until the required stage. ECs were
metabolically stained by inoculating Acetylated low-density lipopro-
teins-Alexa 488 into the heart of E2 or E3 embryos as described
(Jaffredo et al., 1998; Richard et al., 2013; see Supplementary material
and Section 2 for details). Cells from E9 embryos were stained with
CD31-PE (BioLegend, clone MEC13.3 #102507) and CD45-FITC
(BioLegend, clone 30-F11 #103107) antibodies, and AGM cells from
E11.5 embryos with CD144-PE (BioLegend, clone BV13 #138009) and
CD45-FITC. Both chicken and mouse embryo remnants were free of
heart and digestive tract. After staining, cells were rinsed and sorted on
MOFLO ASTRIOS (Beckman Coulter).
2.2. RNA extraction
RNA extraction was performed with RNeasy Mini Kit (Quiagen)
according to the manufacturer's instructions. RNA was conserved at
−80 °C, until reverse transcription.
2.3. Reverse transcription
DNA contamination was removed using DNAse (Ambion). Reverse
transcription was performed according to Cloned AMV First-Strand
cDNA Synthesis Kit (Invitrogen) for chicken RNA or to SuperScript III
First-Strand Synthesis System (Invitrogen) for mouse RNA.
2.4. Quantitative Real-Time PCR
RNA was extracted and reverse transcribed as described above.
Quantitative real time PCR was performed using FAM labeled TaqMan
primers on Light Cycler 480 (Roche). All reactions were run in
triplicates. Data were analyzed using relative quantification and the
2-ΔΔCt. Expression was quantified as fold change relative to gapdh and
18 s RNA expression. Primers are described in Supplementary Table 2.
2.5. In situ Hybridization
For paraffin sections, embryos were fixed in 60% ethanol, 5% acetic
acid and 30% formaldehyde (37% stock solution). After dehydration,
they were embedded in Paraplast (Sigma) and cut at 7 µm.
Hybridization was performed according to (Minko et al., 2003) and
(Wilting et al., 1997).
2.6. RNA Probes
The following chick-specific riboprobes were used: BMP4 was a gift
from Dr M-A Teillet. TGFß2, TGFß3 were gifts from Dr. D. Duprez and
SMAD6 from Dr. Neil Vargesson, Aberdeen University.
2.7. Immunostaining
Origins and dilutions of the antibodies used in the study are
described in Supplementary Table 3. Of note, the anti-P-SMAD 2–3
was raised against P-SMAD2 but also recognized P-SMAD3 and was
designated as anti-P-SMAD2-3 thereafter. The signal was amplified
using the TSA kit, (NEN Life Science). Additional procedures and
secondary antibodies can be found in the supplementary Material and
Methods.
2.8. Embryonic Stem Cell lines (ES) culture
Acvrl1+/+ and Acvrl1+/- ES cell lines were derived and cultured as
described (Czechanski et al., 2014). ES cell lines were cultured in
hanging drops to form EBs as described (Dang et al., 2002). Briefly,
1000 cells were cultured in 22 μl of GMEM supplemented with 20%
FBS, 25 ng.ml-1 VEGF (450-32, Peprotech) and 50 ng ml−1 bFGF (450-
33, Peprotech), hanging from the lid of the culture dish for 5 days
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which allows the formation of cell aggregates. Subsequently, EBs were
plated in 35 mm dish coated with 0.1% gelatin (G1393, Sigma) as
described in medium composed of GMEM with 20% FBS, 25 ng ml−1
VEGF and 50 ng ml−1 bFGF, then cultured for 3, 5 or 7 days at 37 °C in
5% CO2 atmosphere (Li et al., 2014).
3. Results
3.1. Patterns of BMPs, BMP antagonists and TGFßs during the aorta
formation
We first examined the expression patterns of BMP4 and 7 and of
TGFß1, 2 and 3 mRNAs by in situ hybridization (ISH) and immuno-
histology for BMP4 on cross sections at pre-hematopoietic (BMP4) and
hematopoietic stages (BMP4, TGFß2 and 3) of chicken development
with the aim to evaluate their association with the aorta micro-
environment. For comparison, sections were performed at the wing
bud level at the 13-somite stage (Hamburger and Hamilton (HH) stage
12) (Hamburger and Hamilton, 1951) when the embryo is still flat and
the aortas paired, at the 20-somite stage (HH14) upon aortic fusion
and at 3 days (HH19-20). BMP7 mRNA was not found associated with
the vessels in agreement with a previous report (Ahnfelt-Ronne et al.,
2010) and was not investigated further. BMP4 transcript was found in
the dorsal part of the neural tube and the overlying ectoderm and in the
lateral plate at the exception of the somite and the Wolffian duct
(Fig. 1A) in keeping with previously published patterns (Reshef et al.,
1998; Sela-Donenfeld and Kalcheim, 2002; Watanabe and Le Douarin,
1996). Around the aortic region, BMP4 was present underneath the
aortic anlage, in the splanchopleural mesoderm that will form the sub-
aortic mesenchyme (Richard et al., 2013). A similar distribution was
observed at the time of paired aorta fusion (Fig. 1B). Notably, BMP4
mRNA was not expressed by the aortic endothelium.
At the hematopoietic stages, BMP4 protein was found associated
with the sub-aortic mesenchyme and the mesonephros (Fig. 1C) in
keeping with the pattern described for the mouse (Durand et al., 2007)
and human (Marshall et al., 2000) embryo. Of note, the presence of
BMP4 transcript was also detected in this region in the chicken embryo
(our unpublished results and Huber et al. (2008)). TGFß1 ISH did not
give a readable pattern. However TGFß2 and 3 were found in the aortic
floor with TGFß2 associated with the sub-aortic mesenchyme and the
coelomic epithelium (Fig. 1D) and TGFß3 around the aorta likely
associated with the forming smooth muscle cells (Fig. 1E).
Taken together these patterns reveal that the sub-aortic mesench-
yme is highly enriched with BMP4 and TGFß thus delineating a
hematopoietic-promoting microenvironment.
3.2. Phosphorylated SMADs during the aorta formation
To gain insights into the cells that transduced the BMP/TGFß
signal, we next examined the patterns of phosphorylated (P) SMAD1-5-
8 associated with BMP and TGFß signaling and SMAD2-3 linked to
TGFß signaling. SMADS were probed using specific antibodies directed
against the P-SMAD complexes (see Material and Methods and
Supplementary Material and Methods for antibody specificity). A high
P-SMAD1-5-8 signal was found associated with the vessels at the
earliest stages of vascular development (Fig. 2A, arrowheads). Coupling
BMP4 ISH to P-SMAD1-5-8 immunohistology revealed that BMP4-
expressing cells did not co-localize with P-SMAD1-5-8 immuno-
reactive cells except in the dorsal part of the neural tube (compare
Figs. 2A to 2B). At HH12, most of the P-SMAD1-5-8 positive cells were
found associated with the aortic ECs, the dorsal aspect of the neural
tube and the Wolffian duct (Fig. 2B). Immunodetection of P-SMAD2-3
at the nascent-mesoderm stage indicated the presence of numerous
positive cells in the mesoderm, ectoderm and endoderm (Fig. 2C). At
the paired aorta stage the P-SMAD2-3 signal was found in the
ectoderm, endoderm and to a less extent, aortic ECs (Fig. 2D).
At the onset of aortic hematopoiesis, a P-SMAD1-5-8 signal
was detected in cells scattered around the aorta and in the aortic
endothelium that displayed the presence of the earliest CD45+ cells
(Fig. 2E). Of note, CD45, a hematopoietic-specific marker, expression
Fig. 1. In situ hybridization (ISH) and immunohistochemistry patterns of BMP4, TGFß2 and 3 on sections of chicken embryos. HH12 (A), HH14 (B) and HH19-20 (C-E). Black frames
indicate the respective ages on section. A. BMP4 mRNA is expressed in the dorsal part of the neural tube, the overlying ectoderm and the lateral plate mesoderm. B. BMP4 mRNA
expression is present in the dorsal part of the neural tube and the lateral plate mesoderm. C. BMP4 protein expression follows the mRNA pattern (our unpublished results and Huber
et al. (2008)). It is detected in the tissue immediately underneath the aorta and in the mesonephos. Erythrocytes in the aortic lumen display a strong background. Bar=70 µm. D. TGFß2
mRNA is found enriched underneath the aorta and along the coelomic epithelium. E. TGFß3 mRNA is associated with peri-endothelial cells. I-K scale bar=80 µm. Legend: Ao, aorta; C,
coelom; DM, dermomyotome; E, endoderm; M, mesonephros; N, notochord; NT, neural tube; S, somite; So, somatopleural mesoderm; Sp, splanchnopleural mesoderm; WD, Wolffian
duct.
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is accompanied by a progressive decrease of SMAD1-5-8 phosphoryla-
tion in HCs (compare Figs. 2E’ to 2E’’). A similar pattern was observed
for P-SMAD2-3 although the signal was more widely distributed
around the aorta than that of P-SMAD1-5-8 (Fig. 2F-F’’). We also
analyzed the pattern of SMAD6 mRNA, an inhibitory SMAD, by ISH
(Fig. 2G). Of note, SMAD6 was found mostly restricted to the
endothelium but was not present in the hematopoietic clusters in
keeping with its inhibitory role on Runx1 expression shown in the
mouse model (Pimanda et al., 2007).
At the completion of hematopoiesis, the P-SMAD1-5-8 signal was
detected in the endothelium and the immediately surrounding cells
(Fig. 2H).
Finally, we completed the picture by analyzing the P-smad1-5-8
during mouse development. At E9.5, P-SMAD1-5-8 was detected in
ECs of the paired aorta and some cells scattered in the mesenchyme
(Fig. 2I). At E10.5, P-smad1-5-8 was widely distributed in the aortic
region in keeping with a previously published report (Zhang et al.,
2014), not only in ECs but also in cells surrounding the aorta (Fig. 2J).
In conclusion P-SMAD1-5-8 and to a lesser extent, P-SMAD2-3
phosphorylation is a hallmark of ECs from the onset of vascular
formation. During EHT and the subsequent emergence of IHACs, P-
SMAD1-5-8 and P-SMAD2-3 expression decreased on HCs indicating a
down-regulation of the BMP/TGFß pathway. They however remained
expressed by ECs and by cells of the surrounding mesenchyme.
Fig. 2. Expression of phosphorylated (P) SMADS 1-5-8, 2–3 and the inhibitory SMAD6
at the level of the aorta. A-H chicken, I, J mouse. Identical embryonic stages are framed
in black or indicated on individual pictures. A. Composite picture of a cross section
showing BMP4 ISH (left side) and BMP4 ISH combined to immunofluorescence (IF)
detection of p-SMADS 1-5-8 (right side) at the 10-somite stage immediately posterior to
the last formed somites before formation of the aorta. Left. The BMP signal is prominent
in the lateral plate (So + Sp) mesoderm, at the exception of the future somites, and the
dorsal part of the neural tube. Right. The vessels associated with the splanchnopleural
mesoderm display a high P-SMAD 1-5-8 signal localized to the cell nuclei (white
arrowheads). The dorsal part of neural tube and some cells scattered in the ectoderm also
display a visible signal. Of note, cells of the lateral plate express BMP4mRNA but did not
express high levels of P-SMADS 1-5-8. Scale bar=200 µm. B. P-SMADS 1-5-8 IF at the
early paired aorta stage (HH12) showing a strong signal in aortic ECs, Wolffian duct and
peridermis. C-D. P-SMADS 2–3 IF. Posterior part of a 10 somite-stage chicken embryo.
B-D scale Bar=50 µm. C. P-SMADS 2–3 IF signal is more widely distributed than that of
the P-SMADS 1-5-8 being present in the ectoderm, mesoderm (including forming
vessels) and endoderm at the notable expression of the newly formed neural tube. D. P-
SMADS 2–3 IF is visible in the endoderm and ectoderm and to a less extent in aortic ECs
(compare B to D). E-E’’. Combined immunodetection of P-SMADS 1-5-8 and CD45 at the
initiation of hematopoeisis. E. Co-staining for CD45 antigen and P-SMADS 1-5-8. CD45
signal is present in a few cells undergoing EHT in the aortic floor. The P-SMADS 1-5-8
signal is present in both ECs and in some cells localized either immediately underneath
the endothelial layer or scattered in the vicinity of the aorta. E’. Higher magnification of
the frame in E showing CD45 expression in the aortic floor (white arrowheads). E’’. P-
SMADS 1-5-8 expression is decreased in CD45 expressing cells (white arrowheads). F-F”
Combined immunodetection of P-SMADS 2–3 and CD45 at the stage of hematopoietic
clusters. F. P-SMADS 2–3 are present in ECs of the aorta and in cells localized
immediately underneath the endothelial layer. F’. Higher magnification of the frame in
F showing CD45 expression in the aortic floor. F’’. CD45-positive cells are negative for P-
SMADS 2–3 expression (white arrowheads) E-F scale bar=100 µm. G. SMAD 6 ISH at
HH19, mid trunk level. The signal is present in the aortic endothelium but is absent from
the large hematopoietic cluster present in the floor (arrowhead). Scale bar=100 µm. H.
Cross section through the aorta at E4 i.e. post-hematopoietic, stage. P-SMADS 1-5-8
signal is present in the whole aortic endothelium and in the smooth muscle cells
surrounding the vessel. Scale bar=150 µm. I-J. P-SMADS 1-5-8 IF in the prehemato-
poietic (I) and hematopoietic (J) aorta in the mouse embryo. Cross section. Distribution
of P-SMADS is wider than in the chicken at similar embryonic stages. I. ECs of the aorta
(Ao) are positive. Numerous cells of, likely, different origins also display a P-SMADS 1-5-
8 signal. Arrowheads point out aortic ECs expressing P-SMADS 1-5-8. J. Aortic
endothelium is stained. The tissues surrounding the aorta widely express P-SMADS 1-
5-8 in keeping with (Zhang et al., 2014). I-J Scale bar=70 µm. Legend: Ec, ectoderm; CV,
cardinal vein.
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3.3. Revealing BMP signaling with a transgenic mouse to monitor the
transcriptional activity of Smad1-5
We used the transgenic mouse line BRE:gfp reporting P-SMAD1-5
activity through the Id1 promoter (Monteiro et al., 2008) to reveal cells
transducing the BMP/TGFß pathway. We analyzed pre-hematopoietic
and hematopoietic stages for GFP expression and, when useful, co-
detected the GFP signal with the expression of CD31, an endo-
hematopoietic marker. In whole mounts, the GFP signal was strongly
present in the limb bud, embryonic liver and segmental arteries
(Supplementary Fig. 1A). On section, following fixation and GFP
staining using an anti GFP antibody followed by tyramide signal
amplification (see Section 2 and Supplementary Table 2 for details),
GFP was present in the aorta, associated with ECs and in small vessels
around the neural tube and the intestine (Supplementary Fig. 1B) at
the exception of the cardinal veins. A closer view of the aorta revealed
an ensemble of high and low GFP-expressing cells associated with the
endothelium (Supplementary Fig. 1C) in keeping with a previous report
(Crisan et al., 2015). Co-staining with CD31 identified several budding
cells with overlapping signals (Supplementary Fig. 1D, E). Using the
same mouse model, it was recently shown that all hematopoietic stem
cells reside in the GFP+ fraction when cells are isolated in vivo from
E11.5 embryos (Crisan et al., 2015) whereas hematopoietic stem cells
were distributed in both the GFP+ and GFP- fractions when cells were
isolated after a culture period of 3 days (Crisan et al., 2016). Since it
was not completely clear whether the mouse line reported either BMP
or TGFß activity (James et al., 2010; Liang et al., 2009) or both, we
decided to employ a flow cytometry sorting strategy followed by real-
time quantitative PCR (RT-qPCR) to analyze the BMP/TGFß pathway.
3.4. Quantitative PCR analysis of the BMP/TGFß signaling
components in ECs and IHACs at the pre-hematopoietic and
hematopoietic stages of chicken and mouse AGM
Since P-Smad1-5-8 and 2–3 decreased in aortic clusters, we
decided to further characterize the expression of the BMP/TGFß
signaling components in ECs and in HC using RT-qPCR with a
collection of TaqMan probes (Supplementary Table 2) at the pre-
hematopoietic and hematopoietic stages of the AGM in both chicken
and mouse embryos. At pre-hematopoietic stages, AGM ECs were
sorted based on the expression of endothelial-specific markers and the
exclusion of CD45 expression. For the chicken, E2 and E3 embryos
were used. ECs were stained following intra-cardiac inoculation of
human Ac-LDL coupled to Alexa fluor 488 (AF488-Ac-LDL, Molecular
probes). For the mouse, embryos of 20–22 somite pairs i.e., early E9.5
were used. Anti-CD31 (Pecam-1) antibody was chosen to identify ECs.
A mean of 32–37 and 45–47 somite pairs were used to select E10.5 and
E11.5 embryos respectively. Anti VE-Cadherin (CDH5, CD144) and
CD45 antibodies were used to select EC and HC respectively. The IAHC
population was validated for the combined expression of CDH5 and
PTPRC (CD45) as already reported (Richard et al., 2013). The double
negative population (i.e. the embryo remnants) was retained as a
baseline of expression. Accuracy of the sorting was verified with VE-
cadherin and RUNX1 as respectively EC-specific and hemogenic EC-
specific genes for the endothelial fraction (not shown). The plots are
displayed in Supplementary Fig. 2.
For the chicken at the pre-hematopoietic stage, type I receptor
expression was characterized by a strong expression of ACVRL1
(ALK1), a weaker but significant expression of ACVR1 (ALK2) and a
low expression of BMPR1B (ALK6) in ECs. The other type I receptors
BMPR1A (ALK3) and ACVR1B (ALK4) were not significantly expressed
compared to the negative cell fraction (Fig. 3A). A strong expression of
TGFßR2 and a weaker but significant expression of BMPR2 distin-
guished the expression of the type II receptors (Fig. 3B). Type III
receptor expression was characterized by a strong presence of ENG
(ENDOGLIN) and a weaker expression of TGFßR3 (BETAGLYCAN)
(Fig. 3C). Concerning the ligands, BMP4 was weakly expressed in ECs
compared to the rest of the AGM tissues whereas BMP9 and 10 were
not detected at this stage in this tissue (not shown). TGFß2 was not
analyzed in the chicken embryo because no efficient qRT-PCR probe
could be generated and TGFß1 and 3 did not display a statistically
significant signal in ECs. In contrast, BMP4 was significantly down-
regulated in ECs (Fig. 3D). We also analyzed the expression of
SMADs1–8 mRNAs with a special focus in non-phosphorylated
SMADs i.e., SMAD4, 6, 7. For the chicken, no probe for SMAD7 was
found but SMAD6, an inhibitory SMAD, displayed a significantly
increased expression (Fig. 3E) consistent with the ISH pattern
(Fig. 2G).
A similarly consistent pattern was found in the mouse AGM for
Acvrl1, Acvr1 and Bmpr1b as type I receptors, Tgfßr2 as type II
receptors and Eng and Tgfßr3 as type III receptors indicating the
presence of conserved mechanisms (Fig. 3F-J). However Bmpr1a as
type I, Bmpr2 and Acvr2a as type II receptors displayed a different
pattern between the two species. Tgfß1 and Tgfß3 displayed a
significant increase not revealed for the chicken. Tgfß2 was not
significantly expressed in ECs (Fig. 3I) in keeping with its specific role
in heart development (Wagner and Siddiqui, 2009). Neither Bmp2,
Bmp9 nor Bmp10 were detected at this stage in agreement with the
results on the chicken embryo (not shown). Smad6, and to a lesser
extent Smad7, were found increased in the EC fraction (Fig. 3J).
Collectively, the strong presence of Acvrl1 and TgfßR2 as type I and II
receptors respectively indicates that the TGFß pathway acts predomi-
nantly in ECs at the pre-hematopoietic stage and is likely using a
TGFß1 autocrine loop, at least in the mouse species. This receptor
make up is consistent with the expression of P-Smad1-5 in ECs. Since
the antibody we used on section recognized equally P-Smad1-5-8 and
P-Smad1-5 complexes, the prevalence of the TGFß pathway in ECs was
likely.
We next analyzed the expression of the BMP/TGFß pathway in ECs
and IHACs on chick E3 and mouse E11.5 AGM respectively, the
developmental stages where HSPCs were detected (Dzierzak and Speck,
2008; Medvinsky et al., 2011). The same sorting strategy was used
except that VE-cadherin (CD144) replaced CD31 as endothelial-specific
marker for the mouse species. The co-expression of either human
AcLDL-DiI or CD144 and an intermediate level of CD45 (CD45int)
authenticating hematopoietic progenitors was used to isolate IAHCs as
reported (Richard et al., 2013). The double-negative population served
as baseline for RT-qPCR. The TGFß-oriented pattern found at the pre-
hematopoietic stage did not vary significantly for ECs between the pre-
hematopoietic and hematopoietic stages. The hematopoietic fraction
was characterized by a significant decrease of Acvrl1 (Fig. 4A, F) and
Eng (Fig. 4C, H) in both species and a significant decrease of TGFßR2
for the chicken and a tendency to decrease for the mouse (Fig. 4B, G).
TGFßR3 expression also significantly varied between the two fractions
for the chick but not for the mouse. TGFß1, 2 and 3 ligands were
detected but not significantly differentially expressed. This was also the
case for BMP4 (Fig. 4D, I). A strong decrease of SMAD6 was observed
in the IHAC fraction for the chicken (Fig. 4E) whereas the mouse IHAC
fraction displayed a slightly higher level of Smad6 than the EC fraction
(Fig. 4J).
Taken together our results confirmed the prominent expression of
the TGFß pathway through Acvrl1 (Alk1) and TgfßR2 as a hallmark of
ECs. Our data also revealed a downgrading of Acvrl1 and TgfßR2 along
hematopoietic commitment and, contrary to expectations, underlined
the unbalanced pattern for the BMP pathway in AGM hematopoietic
cells.
We performed the same analysis on E10.5 (32–37 somite pairs)
mouse embryos, the time when EHT occurs (Swiers et al., 2013) and
HSPC production reaches a maximum (Yokomizo and Dzierzak, 2010).
Interestingly, EC and IHAC fractions displayed a similar pattern
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(Supplementary Fig. 3) indicating that regarding the BMP/TGFß
pathway, the two cell populations are close to one another. This should
be compared to the pattern found at E11.5 wherein the contrast
between ECs and IHACs is more pronounced.
3.5. Acvrl1 (Alk1) is down regulated in IAHCs
Given the importance of Acvrl1 in hematopoietic production, we
decided to focus on this receptor in the aorta of both chicken and mouse
Fig. 3. RT-qPCR analysis of the BMP/TGFß pathway in AGM ECs at the pre-hematopoietic stage in chicken (A-E) and mouse (F-J) embryos, i.e., E2.5 and early E9.5 (20–22 somite
pairs), respectively. ECs (green) were sorted on the basis of AcLDL uptake (chicken) and CD31 expression (mouse) and the exclusion of CD45 expression. The double negative cell
fraction serves as reference. Relative expression of mRNAs (2-ΔΔCt). A, F. Type I receptors; B, G. Type II receptors; C, H. Type III receptors; D, I. ligands; E, J. Smads. The error bars
represent SEM. ***p < 0.01, **p < 0.25, *p < 0.5.
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species. At the time this study was initiated, no ACVRL1 cDNA sequence
was clearly assigned for the chicken species. Comparison of Ensemble and
NCBI databases allowed isolating a cDNA with a strong homology to
mammalian and non-mammalian Acvrl1 transcripts (Fig. 5A and
Supplementary Results for details). The resulting open reading frame
encoded a putative protein of 498 amino acids containing an activin
receptor domain, a TGFß GS domain and a protein kinase domain
(Fig. 5B), in keeping with the global organization of the receptor.
Fig. 4. RT-qPCR analysis of the BMP/TGFß pathway in AGM ECs and HCs at the hematopoietic stage in chicken (A-E) and mouse (F-J) embryos, i.e., E3.5 and E11.5, respectively. ECs
(green) were sorted on the basis of AcLDL uptake (chicken) and CD144 expression (mouse) and the exclusion of CD45 expression. The hematopoietic cell cluster fraction (red) was sorted on
the basis of the expression of AcLDL uptake (chicken) and CD144 (mouse) and the expression of CD45intermediate. The double negative cell fraction serves as reference. Relative expression of
mRNAs (2-ΔΔCt). A, F. Type I receptors; B, G. Type II receptors; C, H. Type III receptors; D, I. ligands; E, J. Smads. The error bars represent SEM. ***p < 0.01, **p< 0.25, *p < 0.5.
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We next synthetized an ACVRL1 probe (Fig. 5A) and performed in
situ hybridization on chicken embryo section at the time of paired aorta
and aortic hematopoiesis respectively. ACVRL1 signal was restricted to
the endothelial tree being present in the aorta, cardinal veins and
smaller vessels scattered throughout the embryo (Fig. 5C, D). It was
found down-regulated in IAHCs (Fig. 5D) in keeping with the
differential expression revealed by RT-qPCR. Of note TGFßR2, the
only type II receptor for TGFß, was found enriched in ECs and in the
mesonephros region in the chicken embryo (Fig. 5E).
Immunostaining performed on the E11.5 mouse embryo using an
ACVRL1-specific antibody revealed expression in most of the vascular
ECs (Fig. 5F) but an absence on IAHCs (Fig. 5G).
Fig. 5. Chicken ACVRL1 cDNA sequence, protein domains and mRNA expression on chicken embryo section and expression pattern on mouse aorta section. A. Predicted cDNA
sequence of the chicken Acvrl1 gene retrieved from the NCBI database (XM_015300268.1). In black, the cloned cDNA used to synthesize the chicken ISH probe. Start and Stop codons
are in bold. Positions of the forward (direct) and reverse (complementary) primers are indicated. B. Chicken ACVRL1 protein and putative functional domains. Red: extracellular, green:
transmembrane, blue: intracellular. C-D ACVRL1mRNA expression by ISH on sections at prehematopoietic E2.5 (C) and hematopoietic E3 (D) stages. scale bar=70 µm. ACVRL1mRNA
is expressed in ECs of the aorta but not expressed in IAHCS (arrowhead). Scale bar=100 µm. G. Immunodetection of TGFßRII on section. E3 chicken embryo. Scale bar=90 µm E-F.
Immunodetection of Acvrl1 on section of E11.5 aorta of mouse embryo. F. Acvrl1 is present in ECs of most vessels. Scale bar=80 µm. G. Expression is lost in IAHCS (arrowhead). Scale
bar= 30 µm.
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3.6. Acvrl1 haplo insufficiency promotes hematopoietic production
from cultured embryoid bodies
To gain insights into the role of Acvrl1 and the TGFß axis in EHT
and hematopoiesis, we compared Wild-Type (WT) to Acvrl1 hetero-
zygous (Acvrl1+/-) mouse ES cells for their capacity to produce
endothelial and hematopoietic cells from ES cell-derived embryoid
bodies (EBs). The differentiation of ES cells into EBs is a powerful
method to explore the cellular and molecular mechanisms that regulate
embryonic hematopoiesis. WT (IB10 or Thalk1-1 clones) and Acvrl1+/-
(A60-3, A60-2 or Thalk 1–6 clones) EBs were followed over a period of
12 days and checked regularly for the presence of round cells. The first
conspicuous production of round, floating cells was observed around
day 7 and was particularly visible at day 12 around Acvrl1+/- flat cell
colonies whereas few or no round cells were found in the WT colonies
(Fig. 6A, B). Floating cluster-forming cells were visible in the culture
supernatant of Acvrl1+/- EBs (Fig. 6C). We performed FACS analysis
using isolated cells from WT and Acvrl1+/- EBs at day 12 using CD45
and CD144, this latter used as endothelial-specific marker. Acvrl1+/-
cells produced significantly more (1.79 fold, n=3) hematopoietic cells
than their WT counterparts (Fig. 6D); a ratio confirmed (1.3 fold, n=2)
when a time course analysis was performed (Fig. 6E). The percentage
of ECs did not however significantly vary between WT and Acvrl1+/-
cells (not shown). Increased formation of CD45+ cells was further
confirmed on immunohistological analysis of sections of day 12 wt and
Acvrl1+/- EBs using CD45 and CD144 co-immunostainings. WT EBs
displayed CD144 staining and a low CD45 signal (Fig. 6F). In contrast,
Acvrl1+/- EBs showed a strong propensity to express CD45 confirming
the data obtained by flow cytometry (Fig. 6G). Taken together these
results indicate that the level of Avcrl1 influenced the endothelial to
hematopoietic balance in an ex vivo ES differentiation assay in keeping
with the data obtained on the embryonic aorta.
4. Discussion
Using an ensemble of gene expression patterns, RT-qPCR on
purified cell populations and a functional assay using ES cells, we
disclose the critical role of the TGFß pathway through the Alk1-
TgfßR2-Smads1-5 axis to control EHT and hematopoietic production
in the embryonic aorta.
The BMP pathway has long been considered as a main actor in
blood formation. Ventral mesoderm, endothelial and hematopoietic
precursors are induced by BMP4 and inhibited when BMP4 signaling is
impaired (Maeno et al., 1996). In addition, BMP4 has also been shown
to enhance stem cell activity during ex vivo culture of human cord
blood cells (Bhatia et al., 1999) and hematopoietic differentiation of
human ES cells (Chadwick et al., 2003). The prominent presence of
BMP4 in the sub-aortic mesenchyme even reinforce this idea, sugges-
tive of a major role for BMP4 in aortic hematopoiesis (Marshall et al.,
2000; Durand et al., 2007; Wilkinson et al., 2009) and HSC main-
tenance (Durand et al., 2007). We indeed find BMP4 expressed in the
lateral plate mesoderm at the somitic stages and underneath the aorta
during aortic hematopoiesis, but the make up of BMP/TGFß type I and
II receptors in ECs and in emerging hematopoietic cells is not fully
consistent with its prominent role in aorta-associated hematopoiesis.
Interestingly, TGFß2 expression is polarized underneath the aorta
suggesting its possible role in EHT and aortic hematopoiesis. P-
SMAD1-5-8 are expressed in ECs at early stages of development in
line with a previous work (Faure et al., 2002). However the P-SMAD1-
5-8 pattern at these early stages is not totally compatible with the
BMP4 mRNA distribution found in the lateral plate. This discrepancy
may be attributed to a diffusion of active BMP4 to the endothelium or
the existence of other TGFß/BMP ligands utilizing the same SMAD
code for signal transduction. BMP9 and BMP10, two other members of
the BMP family are known to play a role in vascular quiescence (David
et al., 2008) and vascular versus lymphatic EC specification (Kume,
2010) through activation of P-SMAD1-5-8. However none of
these were detected at the stages examined using the sensitive RT-
qPCR method ruling out an early role of these two factors on the
endothelium.
In addition to BMPs, P-SMAD1-5, but not 8, signaling is also used
by the TGFß pathway through the Alk1-Tgfßr2 axis (Lebrin et al.,
2005). P-SMAD2-3 is found in ECs but also detected in other cell types
suggesting a more pleiotropic role. It is known that EC migration and
proliferation are regulated by two distinct TGFß signaling cascades
namely Alk1-Tgfßr2-P-SMAD1-5-8 and Alk5-TgfßR2-P-SMAD2-3 re-
sponsible respectively, for activation and inhibition of EC migration
and proliferation depending on the local concentrations of TGFß
(Goumans et al., 2002). The presence of Endoglin suggests a bias
towards Alk1 and Smad1/5 signaling at the expense of Alk5-Psmad2-3
(Finnson et al., 2010). VE-cadherin, which promotes EC-EC adherens
junctions acts as a critical regulator of type I and II receptor complex
assembly (Rudini et al., 2008). The joint presence of P-smad1-5-8 and
2–3 and of Alk1 and Alk5 may argue for a balanced role of these two
receptors in aortic ECs with a more prominent role of Alk1 during the
activated EC state at these embryonic stages. The fine tuned control of
the EC status is even reinforced by the presence of the inhibitory
Smad6 in aortic ECs in line with a control of Runx1 expression in mice
(Pimanda et al., 2007). In conclusion the prominent expression of
Alk1-Tgfßr2-Endoglin-P-Smad1-5-8 and to a lesser extent of Alk5-
TgfßR2-P-Smad2-3 is a hallmark of aortic ECs before hematopoiesis.
Initiation of aortic hematopoiesis and IAHC formation is accom-
panied by a significant decrease of both the TgfßRII-Acvrl1-Endoglin-
P-Smad1-5-8 axis and the TgfßRII-TgfßRI-P-Smad2-3 axis indicating a
global down-regulation of the pathway as hematopoietic program is
initiated. This down-regulation is completely in keeping with a
decrease of the endothelial identity during EHT associated with the
loss of VE-Cadherin mRNA expression and the gain of PU1 and C-MYB
transcription factors (Richard et al., 2013). The highly similar en-
dothelial and hematopoietic patterns found in the mouse at E10.5 and
the very balanced pattern found at E11.5 is fully in keeping with the
model proposed by De Bruijn and colleagues who report a progressive
loss of endothelial potential by the hemogenic endothelial cell fraction
and an early onset of hematopoietic-specific genes (Swiers et al., 2013).
In Swiers et al., the endo-hematopoietic balance is complete at E10.5.
Using our gene set, we disclose a complete endo-hematopoietic switch
slightly later at E11.5 but used a somewhat different combination of
markers with VE-Cadherin and CD45int expression that may explain
the discrepancy. Smad6 an inhibitor of BMP/TGFß signaling, is down-
regulated in IAHC as revealed by in situ hybridization and RT-qPCR.
This is in keeping with a proposed feedback loop in which Smad6
inhibits Runx1 by mediating its degradation by the proteasome
(Pimanda et al., 2007).
In addition to its physiological role in developing ECs, TGFß
signaling is also implicated in EMT that turns epithelial cells into
mobile mesenchymal cells, a mechanism integral to development but
also to wound healing and cancer (Lamouille et al., 2014).
Interestingly, ECs can transdifferentiate into a mesenchymal cell/stem
cell phenotype, a process known as EndMT developmentally required
for the formation of endocardial cushions and involved in fibroblast
accumulation in mouse models of renal, pulmonary and cardiac fibrosis
(Medici and Kalluri, 2012; van Meeteren and ten Dijke, 2012). EndMT
is characterized by the down-regulation of the junction-specific mole-
cules VE-Cadherin, CD31 and Claudin-5 through the expression of the
transcription factor Snail and is induced by either TGFß2 or BMP4.
EMT and EndMT are indeed reminiscent of EHT since EndMT results
in the activation of a mesenchymal cell and stem cell program and EHT
into the activation of hematopoietic cell and HSC program. Whether
EndMT and EHT employ similar if not identical molecular mechanisms
is not known but is likely. Our recent results indicate that the sub-
aortic mesenchyme plays a key role in the initiation of Runx1
expression and hematopoietic emergence (Richard et al., 2013). To
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understand the mechanism by which the sub-aortic mesenchyme
informs ECs awaits further investigation.
Experiments using EBs differentiated from Acvrl1+/- mouse ES
cells suggest a bias towards the hematopoietic lineage. This is in
keeping with a specific requirement for Alk1 in EHT and early
hematopoietic commitment that we disclose using gene expression
studies. This also indicates that, in addition to its role in EC home-
ostasis, Acvrl1 plays a pivotal role in the EC versus hematopoietic cell
commitment/differentiation.
Taken together, we unveil here the requirement for TGFß signaling
Fig. 6. Hematopoietic and endothelial production in WT Acvrl1+/+ and Acvrl1+/- embryoid bodies. A-B. representative images culture of embryoid body colonies of WT (A) or Acvrl1+/-
(B) at 6, 8, 10 and 12 days of culture. Note the increasing number of round cells in the Acvrl1+/- condition. C High magnification of round cell clusters at day 12 of Acvrl1+/- culture of
embryoid bodies. D, E. Comparison by flow cytometry analysis between Acvrl1+/+ and Acvrl1+/- CD45+ hematopoietic cells produced at day 12 (D) and a follow up at day 8, 10, 12 (E) of
culture of embryoid bodies. F, G. Immunohistological analysis of CD144 (green) and CD45 (red) on sections of Acvrl1+/+ (F) and Acvrl1+/- (G) embryoid bodies. Scale bar=15 µm.
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to control EHT and hematopoietic commitment in vivo and ex vivo.
Identification of the spatial and temporal requirements will be instru-
mental for the future generation of hemogenic endothelium and
hematopoietic production ex vivo from various cellular sources for
therapeutic purposes.
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